Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Clarissa D. Weitzer"'
Autor:
Johanna Färbinger, Hanfeng Guan, Thomas Wirth, Marion J. Vogel, Frank Leithäuser, Olga Ritz, Karlheinz Holzmann, Clarissa D. Weitzer, Alexey Ushmorov, Linka Xie, Peter Möller, Franziska Gehringer, Silke Brüderlein
Publikováno v:
Oncotarget
// Linka Xie 1,2,* , Olga Ritz 3,* , Frank Leithauser 3 , Hanfeng Guan 2,4 , Johanna Farbinger 2 , Clarissa D Weitzer 2 , Franziska Gehringer 2 , Silke Bruderlein 3 , Karlheinz Holzmann 5 , Marion J. Vogel 2 , Peter Moller 3 , Thomas Wirth 2 and Alex
Autor:
Silvia Paoletta, Clarissa D. Weitzer, Vsevolod Katritch, Kenneth A. Jacobson, T. Kendall Harden, Evgeny Kiselev, Qiang Zhao, Kyle A. Brown, Andrew L. Yin, Raymond C. Stevens, Matthew O. Barrett, Eva Hammes
Publikováno v:
ACS Chemical Biology
The P2Y14 receptor (P2Y14R), one of eight P2Y G protein-coupled receptors (GPCR), is involved in inflammatory, endocrine, and hypoxic processes and is an attractive pharmaceutical target. The goal of this research is to develop high-affinity P2Y14R f
Publikováno v:
The Journal of Pathology. 229:775-783
Burkitt lymphoma (BL) is caused by translocation of the MYC gene to an immunoglobulin locus resulting in its constitutive expression depending on the activity of the immunoglobulin (Ig) enhancer elements. Treatment of BL cell lines with epigenetic mo
Autor:
Juliana I. Sesma, Scott H. Donaldson, Clarissa D. Weitzer, Eduardo R. Lazarowski, Hong Dang, Kenneth A. Jacobson, Alessandra Livraghi-Butrico, T. Kendall Harden, Neil E. Alexis
In addition to their role in glycosylation reactions, UDP-sugars are released from cells and activate widely distributed cell surface P2Y 14 receptors (P2Y 14 R). However, the physiological/pathophysiological consequences of UDP-sugar release are inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9565e64ec53b6956639d487510cabf7
Autor:
Reuben Tooze, Marion J. Vogel, Anita B. Kick, Fong Chun Chan, Christian Steidl, Ethel Cesarman, Harald J. Maier, Peter Møller, Jonathan Reichel, Alexey Ushmorov, Franziska Gehringer, Karlheinz Holzmann, Hanfeng Guan, Clarissa D. Weitzer, Ulrike Kostezka, Thomas Wirth, Thomas Maier, Mikhail Roshal, Randy D. Gascoyne, Linka Xie
Publikováno v:
Blood. 124(20)
The survival of classical Hodgkin lymphoma (cHL) cells depends on activation of NF-κB, JAK/STAT, and IRF4. Whereas these factors typically induce the master regulator of plasma cell (PC) differentiation PRDM1/BLIMP-1, levels of PRDM1 remain low in c
Autor:
Alexey Ushmorov, Klaus-Michael Debatin, Franziska Gehringer, Lüder Hinrich Meyer, Thomas Wirth, Fan Wang, Salih Demir, Clarissa D. Weitzer
Publikováno v:
Blood. 128:4020-4020
Acute lymphoblastic leukemia (ALL) is the most common pediatric and adolescent malignancy. Although current treatment provides five-year event-free survival, in up to 20% conventional chemotherapy fails resulting in relapse with inferior prognosis. F
Autor:
Hanfeng, Guan, Linka, Xie, Kay, Klapproth, Clarissa D, Weitzer, Thomas, Wirth, Alexey, Ushmorov
Publikováno v:
The Journal of pathology. 229(5)
Burkitt lymphoma (BL) is caused by translocation of the MYC gene to an immunoglobulin locus resulting in its constitutive expression depending on the activity of the immunoglobulin (Ig) enhancer elements. Treatment of BL cell lines with epigenetic mo
Autor:
Marion J. Vogel, Linka Xie, Hanfeng Guan, Clarissa D. Weitzer, Frank Leithäuser, Peter Moeller, Thomas Wirth, Alexey Ushmorov
Publikováno v:
Blood. 122:3794-3794
In contrast to other B cell lymphomas, Hodgkin and Reed-Sternberg (HRS) cells, the malignant cells of classical Hodgkin lymphoma (cHL), have mainly lost their B cell identity. Recently, we reported that the transcription factor FOXO1, indispensable f
Autor:
Guan, Hanfeng, Xie, Linka, Klapproth, Kay, Weitzer, Clarissa D, Wirth, Thomas, Ushmorov, Alexey
Publikováno v:
Journal of Pathology; Apr2013, Vol. 229 Issue 5, p775-783, 9p